Effect of sympathetic nervous system on blood pressure

E-posters: CARDIOVASCULAR RISK FACTORS

SYMPATHETIC NERVOUS SYSTEM ACTIVITY AND BLOOD PRESSURE IN HYPERTENSIVE PATIENTS WITH NONALCOHOLIC FATTY LIVER DISEASE

Kakouri, Niki; Andrikou, Ioannis; Konstantinidis, Dimitrios; Siafi, Eirini; Kariori, Maria; Drogkaris, Sotirios; Polyzos, Dimitrios; Manta, Eleni; Tatakis, Fotis; Grigoriou, Kalliopi; Zammanis, Ioannis; Iliakis, Panagiotis; Papakonstantinou, Pantelis; Thomopoulos, Costas; Tsioufis, Konstantinos

First Cardiology Clinic, Medical School, National and Kapodistrian University of Athens, Hippokration Hospital, Athens, GREECE

doi: 10.1097/01.hjh.0000836508.44305.18

  • Free

Abstract

Copyright © 2022 Wolters Kluwer Health, Inc. All rights reserved.

Abstract

Blood pressure changes occurring over a 24-h period are under behavioral, humoral and reflex regulation. The sympathetic nervous system modulates blood pressure variation by affecting cardiac output and peripheral vascular resistance. This paper reviews evidence for the relationship between adrenergic neural drive and blood pressure as measured by direct and indirect approaches. This paper also reviews the sympathetic activity associated with increased ‘in-office’ and ‘out-of-office’ blood pressure, that is, the white-coat and the masked-hypertensive states. Finally, this paper examines altered neuroadrenergic influences on nocturnal blood pressure reduction and blood pressure variability.

Introduction

Blood pressure undergoes considerable change during a 24-h period, showing both rapid fluctuations lasting a few cardiac cycles and prolonged variations, such as those distinguishing daytime from nighttime blood pressure.1, 2 Clinical evidence shows that both short- and long-term blood pressure variations occurring during a 24-h period increase progressively as subjects advance from normotensive to hypertensive.3 Evidence also indicates that the prevalence and severity of end-organ damage from hypertension is closely related to the 24-h blood pressure average and blood pressure variability.4, 5, 6 Finally, further studies unequivocally show that the magnitude of blood pressure variability has major prognostic relevance and predicts both nonfatal and fatal cardiovascular events.4, 7, 8 Collectively, these studies emphasize the clinical importance of spontaneous blood pressure oscillations and validate this variability as a target of antihypertensive drug treatment.

Despite the vast accumulated information on the clinical relevance of blood pressure variation, the mechanisms responsible for blood pressure variability still remain largely undefined. This paper examines the mechanisms responsible for daytime blood pressure variation. Emphasis will be given to the influences from the sympathetic nervous system or ‘neurogenic factors’ involved in daytime blood pressure regulation.

Mechanisms involved in diurnal blood pressure variations

Blood pressure recording using invasive or noninvasive devices permits measurement under various conditions, including static or dynamic exercise, daily living under stressful conditions, cigarette smoking and sleep. With the exception of sleep, all the above-mentioned conditions increase blood pressure, blood pressure variability and oscillations.9 By contrast, sleep is associated with reduced blood pressure and reduced blood pressure variability, regardless of whether sleep takes place during the nighttime or daytime period.9 Blood pressure changes have been ascribed to the so-called ‘behavioral influences,’ including environmental factors, response to physical or emotional stressors, as well as baroreflex and/or neural mechanisms that regulate cardiovascular responses to exogenous stimuli (Figure 1).

Figure 1

Effect of sympathetic nervous system on blood pressure

Schematic drawing illustrating the possible mechanisms involved in modulating blood pressure (BP) variability. The symbol (+) means excitatory influences increasing BP variability, whereas the symbol (−) means inhibitory influences reducing BP variability. Question marks refer to the influences not yet fully defined.

Full size image

The wide range in 24-h (and particularly daytime) blood pressure variability among subjects may originate from varied baroreflex response.9 This hypothesis is based on evidence that in experimental animals, sino-aortic denervation or the surgical ablation of carotid baroreceptors is accompanied by a three-fold increase in blood pressure variability.10, 11 However, diurnal blood pressure variation and circadian blood pressure rhythms depend on the influences of other factors, such as the renin–angiotensin system,12, 13 vasomotor tone14 and cyclic variations in plasma norepinephrine and epinephrine, as shown previously in studies that measured catecholamines in cerebrovascular regions or in the plasma reservoir12, 15, 16, 17 (Figure 2). Direct recording of efferent postganglionic muscle sympathetic nerve traffic can now be accomplished using the microneurographic technique. This approach reveals new information on the role of sympathetic neural factors in diurnal blood pressure changes and the pathogenesis of human hypertension.18

Figure 2

Effect of sympathetic nervous system on blood pressure

Changes in plasma norepinephrine (NE) and systolic blood pressure (SBP) as related to subject behavior and activity during a 24-h period. Figure modified from Watson et al.16

Full size image

Sympathetic mechanisms and diurnal blood pressure

Sympathetic neural mechanisms regulate the two main cardiovascular variables involved in the determination of blood pressure, that is, cardiac output and peripheral resistance.18 High blood pressure is triggered by increased sympathetic influence on the heart and peripheral vessels that leads to hyperkinetic circulation and peripheral vasoconstriction, respectively.18, 19, 20 The literature further supports that sympathetic neural factors exert a key role not only in the development and progression of hypertension but also in the pathogenesis of hypertension-related cardiovascular and renal end-organ damage.18

A number of studies have also examined whether and to what extent sympathetic neural mechanisms participate in two forms of hypertension of recent definition, that is, ‘white-coat’ and ‘masked’ hypertension. White-coat hypertension is characterized by elevated clinically measured blood pressure but normal ambulatory daytime blood pressure. Masked hypertension is characterized by normal clinically measured blood pressure but elevated ambulatory daytime blood pressure.21 Direct and indirect approaches to assess human sympathetic function have been used to determine the sympathetic contribution to the above-mentioned conditions. For indirect approaches, power spectral analysis of the heart rate signal have shown that the low- to high-frequency ratio, considered as an index of sympathovagal balance, is increased in white-coat hypertension, which suggests increased sympathetic and decreased parasympathetic drive to the heart.22, 23, 24 However, these studies did not provide information on systemic sympathetic activity, that is, of the adrenergic influences that modulate peripheral vasomotor tone and vascular resistance. This limitation can be circumvented by recording efferent postganglionic muscle sympathetic nerve traffic using the microneurographic approach that measures adrenergic outflow to peripheral vessels.18 Two studies used this approach to determine the neurogenic contribution to white-coat hypertension and masked hypertension.25, 26 Results showed that white-coat hypertension was characterized by marked elevation in muscle sympathetic nerve traffic, both when assessed as sympathetic burst incidence over time and when corrected for heart rate (Figure 3). A similar phenomenon was detected in masked hypertension (Figure 3). Finally, the magnitude of adrenergic overdrive detected in both white-coat and masked hypertension appears similar to that of established hypertension, the condition with elevated clinically measured and daytime ambulatory blood pressure (Figure 3). Collectively, these findings suggest that several forms of hypertension share marked adrenergic overdrive that involves the cardiac district and the entire cardiovascular system.

Figure 3

Effect of sympathetic nervous system on blood pressure

Mean values (±s.e.) of muscle sympathetic nerve traffic (MSNA), expressed as burst incidence over time (left panel) and corrected for heart rate values (right panel), in patients with white-coat hypertension (WCHT), established hypertension (EHT) or masked hypertension (MHT). Data collected in a group of normotensive subjects (NT) are also shown. Asterisks (**P<0.01) refer to the statistical significance between groups. Figure modified from Grassi et al.26

Full size image

Morning blood pressure surge and sympathetic activity

As mentioned previously, plasma catecholamine levels undergo marked changes during a 24-h period, increasing in the early morning hours upon wakening.12, 15, 16, 17 Circadian variation in plasma adrenergic neurotransmitters supports the hypothesis that the morning surge in blood pressure has a neurogenic component that depends on sympathetic activation. Although intriguing, this hypothesis has received only indirect support from the markers of elevated plasma norepinephrine and heart rate. However, these two markers are not conclusive for sympathetic activation. Increased plasma norepinephrine may be ascribed not only to augmented sympathetic drive but also to reduced tissue clearance of norepinephrine due to altered tissue perfusion.27 Similarly, increased heart rate does not necessarily imply increased cardiac sympathetic neural activity, given that the reduced inhibitory drive by the parasympathetic nervous system may also trigger a tachycardic response.28 The microneurographic approach may show increased sympathetic neural drive in the early morning hours. Abnormal increases in early morning blood pressure may be accompanied by increased sympathetic nerve activity.29, 30 The issue has important clinical and therapeutic implications because exaggerated morning blood pressure surge is associated with a greater risk of cerebrovascular and cardiovascular events.30, 31, 32, 33 Therapeutic implications could include the use of antihypertensive drugs that are capable of reducing adrenergic activation to achieve a better blood pressure control in the early morning hours.34

Two additional factors may affect sympathetic neural influence on diurnal and early morning blood pressure variation, blood pressure patterns during sleep and sleep apnea. The morning surge in blood pressure may depend on the magnitude of blood pressure reduction during sleep. Blood pressure change patterns during sleep described as dipping, nondipping, extreme dipping or reverse dipping are under profound sympathetic neural influence. A recent study conducted by our group assessed sympathetic activity in the peroneal nerve using the microneurographic approach in middle-age normotensive and hypertensive subjects showing patterns of dipping, nondipping, extreme dipping and reverse dipping.35 The results in Figure 4 show that sympathetic drive in hypertensive subjects is similar among dipper, nondipper and extreme dipper patterns, but is higher in the reverse dipper pattern. These findings again confirm that sympathetic activation is a major mechanism for determining the difference between day and evening blood pressure. Obstructive sleep apnea also impacts diurnal blood pressure variation and hypertension.36 This effect depends on the marked adrenergic overdrive caused by abnormalities in the apnea/hypopnea index as measured by nighttime polysomnographic evaluation.37, 38

Figure 4

Effect of sympathetic nervous system on blood pressure

Upper panels. Day:night systolic and diastolic blood pressure (SBP and DBP, respectively) ratio in normotensive subjects (NT) and in hypertensive patients with a dipping hypertension (DHT), nondipping hypertension (NDHT), extreme dipping hypertension (EDHT) and reverse dipping hypertension (RDHT) profile. Data are shown as mean percentage values (±s.e.). Lower panels: values of muscle sympathetic nerve traffic (MSNA), expressed as bursts incidence over time (left panel) and corrected for heart rate values (right panel). Asterisks (*P<0.05 and **P<0.01) refer to the statistical significance between HT and NT groups. The symbol (†) refers to the statistical significance (P<0.05) between RDHT and the other HT groups. Data are shown as mean absolute values±s.e. Figure modified from Grassi et al.35

Full size image

Blood pressure variability and sympathetic neural factors

Blood pressure variability is influenced by sympathetic factors. Originally documented in experimental animals,39 this finding has also been confirmed in humans by spectral analysis of heart rate40 and more recently by the direct microneurographic approach.41, 42 The results of these microneurographic studies can be summarized as follows. First, normotensive subjects with higher sympathetic nerve traffic display greater daytime blood pressure variability.41 Second, normotensive subjects with higher sympathetic nerve traffic have more pronounced declines in nighttime blood pressure.41 Finally, studies in elderly normotensive subjects showed that sympathetic neural factors modulate the cyclic components of blood pressure variability that significantly contribute to blood pressure variation. By contrast, noncyclic and residual components of blood pressure variability (that is, the erratic changes in blood pressure not regulated by specific mechanisms) do not display significant relationships with sympathetic neural factors.42 Collectively, these findings suggest that sympathetic mechanisms regulate absolute blood pressure values and their variability throughout the 24-h period.

Conclusions

Increasing evidence supports the hypothesis that sympathetic neural mechanisms significantly contribute to diurnal blood pressure variation and to absolute blood pressure variability. It is likely that altered sympathetic neural influences interact with other humoral or reflex mechanisms and increase the complexity of the servo-control process regulating absolute blood pressure and diurnal blood pressure variation.

References

  1. Ogihara T, Kikuchi K, Matsuoka H, Fujita T, Higaki J, Horiuchi M, Imai Y, Imaizumi T, Ito S, Iwao H, Kario K, Kawano Y, Kim-Mitsuyama S, Kimura G, Matsubara H, Matsuura H, Naruse M, Saito I, Shimada K, Shimamoto K, Suzuki H, Takishita S, Tanahashi N, Tsuchihashi T, Uchiyama M, Ueda S, Ueshima H, Umemura S, Ishimitsu T, Rakugi H . Japanese Society of Hypertension Committee. The Japanese Society of Hypertension Guidelines for the Management of Hypertension. Chapter 2. Measurement and clinical evaluation of blood pressure. Hypertens Res 2009; 32: 11–23.

    Article  Google Scholar 

  2. Mancia G, Parati G . The role of blood pressure variability in end-organ damage. J Hypertens 2003; 21: S17–S23.

    Article  CAS  Google Scholar 

  3. Mancia G, Ferrari A, Gregorini L, Parati G, Pomidossi G, Bertinieri G, Grassi G, di Rienzo M, Pedotti A, Zanchetti A . Blood pressure and heart rate variabilities in normotensive and hypertensive human beings. Circ Res 1983; 53: 96–104.

    Article  CAS  Google Scholar 

  4. Frattola A, Parati G, Cuspidi C, Albini F, Mancia G . Prognostic value of 24-h blood pressure variability. J Hypertens 1993; 11: 1133–1137.

    Article  CAS  Google Scholar 

  5. Sander D, Kukla C, Klingelhöfer J, Winbeck K, Conrad B . Relationship between circadian blood pressure patterns and progression of early carotid atherosclerosis: a 3-year follow-up study. Circulation 2000; 102: 1536–1541.

    Article  CAS  Google Scholar 

  6. Sega R, Corrao G, Bombelli M, Beltrame L, Facchetti R, Grassi G, Ferrario M, Mancia G . Blood pressure variability and organ damage in a general population: results from the PAMELA study (Pressioni Arteriose Monitorate E Loro Associazioni). Hypertension 2002; 39: 710–714.

    Article  CAS  Google Scholar 

  7. Kikuya M, Hozawa A, Ohokubo T, Tsuji I, Michimata M, Matsubara M, Ota M, Nagai K, Araki T, Satoh H, Ito S, Hisamichi S, Imai Y . Prognostic significance of blood pressure and heart rate variabilities: the Ohasama study. Hypertension 2000; 36: 901–906.

    Article  CAS  Google Scholar 

  8. White WB . Relevance of blood pressure variation in the circadian onset of cardiovascular events. J Hypertens 2003; 21: S9–S15.

    Article  CAS  Google Scholar 

  9. Mancia G, Parati G, Di Rienzo M, Zanchetti A . Blood pressure variability. In Zanchetti A, Mancia G (eds). Pathogenesis of Hypertension—Handbook of Hypertension. vol. 17, Elsevier Science: New York, 1997, pp 117–169.

    Google Scholar 

  10. Krieger EM . Neurogenic hypertension in the rat. Circ Res 1964; 15: 511–521.

    Article  CAS  Google Scholar 

  11. Cowley Jr AW, Liard JF, Guyton AC . Role of baroreceptor reflex in daily control of arterial blood pressure and other variables in dogs. Circ Res 1973; 32: 564–576.

    Article  Google Scholar 

  12. Tuck ML, Stern N, Sowers JR . Enhanced 24-h norepinephrine and renin secretion in young patients with essential hypertension: relation with the circadian pattern of arterial blood pressure. Am J Cardiol 1985; 55: 112–115.

    Article  CAS  Google Scholar 

  13. Masuda S, Tamura K, Wakui H, Kanaoka T, Ohsawa M, Maeda A, Dejima T, Yanagi M, Azuma K, Umemura S . Effects of angiotensin II type 1 receptor blocker on ambulatory blood pressure variability in hypertensive patients with overt diabetic nephropathy. Hypertens Res 2009; 32: 950–955.

    Article  CAS  Google Scholar 

  14. Deyneli O, Yazici D, Toprak A, Yuksel M, Aydin H, Tezcan H, Yavuz DG, Akalin S . Diurnal blood pressure abnormalities are related to endothelial dysfunction in patients with non-complicated type 1 diabetes. Hypertens Res 2008; 31: 2065–2073.

    Article  Google Scholar 

  15. Ziegler MG, Lake CR, Foppen FH, Shoulson I, Kopin IJ . Norepinephrine in cerebrospinal fluid. Brain Res 1976; 108: 436–440.

    Article  CAS  Google Scholar 

  16. Watson RD, Hamilton CA, Reid JL, Littler WA . Changes in plasma norepinephrine, blood pressure and heart rate during physical activity in hypertensive man. Hypertension 1979; 1: 341–346.

    Article  CAS  Google Scholar 

  17. Panza JA, Epstein SE, Quyyumi AA . Circadian variation in vascular tone and its relation to alpha-sympathetic vasoconstrictor activity. N Engl J Med 1991; 325: 986–990.

    Article  CAS  Google Scholar 

  18. Grassi G . Assessment of sympathetic cardiovascular drive in human hypertension: achievements and perspectives. Hypertension 2009; 54: 690–697.

    Article  CAS  Google Scholar 

  19. Mark AL . The sympathetic nervous system in hypertension: a potential long-term regulator of arterial pressure. J Hypertens 1996; 14: S159–S165.

    CAS  Google Scholar 

  20. Schlaich MP, Lambert E, Kaye DM, Krozowski Z, Campbell DJ, Lambert G, Haskings J, Aggarwal A, Esler MD . Sympathetic augmentation in hypertension: role of nerve firing, norepinephrine reuptake, and angiotensin neuromodulation. Hypertension 2004; 43: 169–175.

    Article  CAS  Google Scholar 

  21. Parati G, Stergiou GS, Asmar R, Bilo G, de Leeuw P, Imai Y, Kario K, Lurbe E, Manolis A, Mengden T, O’Brien E, Ohkubo T, Padfield P, Palatini P, Pickering T, Redon J, Revera M, Ruilope LM, Shennan A, Staessen JA, Tisler A, Waeber B, Zanchetti A, Mancia G . European Society of Hypertension guidelines for blood pressure monitoring at home: a summary report of the Second International Consensus Conference on Home Blood Pressure Monitoring. J Hypertens 2008; 26: 1505–1526.

    Article  CAS  Google Scholar 

  22. Pierdomenico SD, Bucci A, Costantini F, Lapenna D, Cuccurullo F, Mezzetti A . Twenty-four-hour autonomic nervous function in sustained and ‘white coat’ hypertension. Am Heart J 2000; 140: 672–677.

    Article  CAS  Google Scholar 

  23. Neumann SA, Jennings JR, Muldoon MF, Manuck SB . White-coat hypertension and autonomic nervous system dysregulation. Am J Hypertens 2005; 18: 584–588.

    Article  Google Scholar 

  24. Fagard RH, Stolarz K, Kuznetsova T, Seidlerova J, Tikhonoff V, Grodzicki T, Nikitin Y, Filipovsky J, Peleska J, Casiglia E, Thijs L, Staessen JA, Kawecka-Jaszcz K . Sympathetic activity, assessed by power spectral analysis of heart rate variability, in white-coat, masked and sustained hypertension versus true normotension. J Hypertens 2007; 25: 2280–2285.

    Article  CAS  Google Scholar 

  25. Smith PA, Graham LN, Mackintosh AF, Stoker JB, Mary DA . Sympathetic neural mechanisms in white-coat hypertension. J Am Coll Cardiol 2002; 40: 126–132.

    Article  Google Scholar 

  26. Grassi G, Seravalle G, Quarti-Trevano F, Dell’Oro R, Bolla G, Cuspidi C, Arenare F, Mancia G . Neurogenic abnormalities in masked hypertension. Hypertension 2007; 50: 537–542.

    Article  CAS  Google Scholar 

  27. Esler M, Jennings G, Lambert G, Meredith I, Horne M, Eisenhofer G . Overflow of catecholamine neurotransmitters to the circulation: source, fate, and functions. Physiol Rev 1990; 70: 963–985.

    Article  CAS  Google Scholar 

  28. Mancia G, Lusher TF, Shepherd JT, Noll G, Grassi G . Cardiovascular regulation: basic considerations. In Willerson JT, Cohn JN, Wellens HIJ, Holmes DR Jr (eds). Cardiovascular Medicine. Springer Verlag: London, 2007, pp 1525–1536.

    Chapter  Google Scholar 

  29. Yano Y, Kario K . Possible difference in the sympathetic activation on extreme dippers with or without exaggerated morning surge. Hypertension 2009; 53: e1.

    Article  CAS  Google Scholar 

  30. Grassi G, Seravalle G, Quarti-Trevano F, Dell’Oro R, Bombelli M, Cuspidi C, Facchetti R, Bolla G, Mancia G . Response to possible difference in the sympathetic activation on extreme dippers with or without exaggerated morning surge. Hypertension 2009; 53: e2.

    CAS  Google Scholar 

  31. Kario K, Ishikawa J, Pickering TG, Hoshide S, Eguchi K, Morinari M, Hoshide Y, Kuroda T, Shimada K . Morning hypertension: the strongest independent risk factor for stroke in elderly hypertensive patients. Hypertens Res 2006; 29: 581–587.

    Article  Google Scholar 

  32. Kario K, Pickering TG, Umeda Y, Hoshide S, Hoshide Y, Morinari M, Murata M, Kuroda T, Schwartz JE, Shimada K . Morning surge in blood pressure as a predictor of silent and clinical cerebrovascular disease in elderly hypertensives: a prospective study. Circulation 2003; 107: 1401–1406.

    Article  Google Scholar 

  33. Amici A, Cicconetti P, Sagrafoli C, Baratta A, Passador P, Pecci T, Tassan G, Verrusio W, Marigliano V, Cacciafesta M . Exaggerated morning blood pressure surge and cardiovascular events. A 5-year longitudinal study in normotensive and well-controlled hypertensive elderly. Arch Gerontol Geriatr 2009; 49: e105–e109.

    Article  CAS  Google Scholar 

  34. Kario K, Matsui Y, Shibasaki S, Eguchi K, Ishikawa J, Hoshide S, Ishikawa S, Kabutoya T, Schwartz JE, Pickering TG, Shimada K . An alpha-adrenergic blocker titrated by self-measured blood pressure recordings lowered blood pressure and microalbuminuria in patients with morning hypertension: the Japan Morning Surge-1 Study. J Hypertens 2008; 26: 1257–1265.

    Article  CAS  Google Scholar 

  35. Grassi G, Seravalle G, Quarti-Trevano F, Dell’Oro R, Bombelli M, Cuspidi C, Facchetti R, Bolla G, Mancia G . Adrenergic, metabolic, and reflex abnormalitiesin reverse and extreme dipper hypertensives. Hypertension 2008; 52: 925–931.

    Article  CAS  Google Scholar 

  36. Nagata K, Osada N, Shimazaki M, Kida K, Yoneyama K, Tsuchiya A, Yasuda T, Kimura K . Diurnal blood pressure variation in patients with sleep apnea syndrome. Hypertens Res 2008; 31: 185–191.

    Article  CAS  Google Scholar 

  37. Narkiewicz K, van de Borne PJ, Cooley RL, Dyken ME, Somers VK . Sympathetic activity in obese subjects with and without obstructive sleep apnea. Circulation 1998; 98: 772–776.

    Article  CAS  Google Scholar 

  38. Grassi G, Facchini A, Quarti-Trevano F, Dell’Oro R, Arenare F, Tana F, Bolla G, Monzani A, Robuschi M, Mancia G . Obstructive sleep apnea-dependent and -independent adrenergic activation in obesity. Hypertension 2005; 46: 321–325.

    Article  CAS  Google Scholar 

  39. Oosting J, Struijker-Boudier HA, Janssen BJ . Autonomic control of ultradian and circadian rhythms of blood pressure, heart rate, and baroreflex sensitivity in spontaneously hypertensive rats. J Hypertens 1997; 15: 401–410.

    Article  CAS  Google Scholar 

  40. Kario K, Motai K, Mitsuhashi T, Suzuki T, Nakagawa Y, Ikeda U, Matsuo T, Nakayama T, Shimada K . Autonomic nervous system dysfunction in elderly hypertensive patients with abnormal diurnal blood pressure variation: relation to silent cerebrovascular disease. Hypertension 1997; 30: 1504–1510.

    Article  CAS  Google Scholar 

  41. Narkiewicz K, Winnicki M, Schroeder K, Phillips BG, Kato M, Cwalina E, Somers VK . Relationship between muscle sympathetic nerve activity and diurnal blood pressure profile. Hypertension 2002; 39: 168–172.

    Article  Google Scholar 

  42. Dell’Oro R, Quarti-Trevano F, Facchetti R, Seravalle G, Bombelli M, Polo Fritz H, Sega R, Grassi G, Mancia G . Overall, cyclic and non-cyclic 24-h blood pressure variability and sympathetic nerve traffic in the elderly. J Hypertens 2003; 21: S213 (abstract).

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Clinica Medica, Ospedale San Gerardo, Università Milano-Bicocca, Monza, Italy

    Guido Grassi, Michele Bombelli, Gino Seravalle, Raffaella Dell'Oro & Fosca Quarti-Trevano

  2. Istituto Auxologico Italiano, Milan, Italy

    Guido Grassi & Gino Seravalle

Authors

  1. Guido Grassi

    You can also search for this author in PubMed Google Scholar

  2. Michele Bombelli

    You can also search for this author in PubMed Google Scholar

  3. Gino Seravalle

    You can also search for this author in PubMed Google Scholar

  4. Raffaella Dell'Oro

    You can also search for this author in PubMed Google Scholar

  5. Fosca Quarti-Trevano

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Guido Grassi.

Rights and permissions

About this article

Cite this article

Grassi, G., Bombelli, M., Seravalle, G. et al. Diurnal blood pressure variation and sympathetic activity. Hypertens Res 33, 381–385 (2010). https://doi.org/10.1038/hr.2010.26

Download citation

  • Received: 26 January 2010

  • Accepted: 29 January 2010

  • Published: 05 March 2010

  • Issue Date: May 2010

  • DOI: https://doi.org/10.1038/hr.2010.26

Keywords

  • dipping profile
  • masked hypertension
  • sympathetic nervous system
  • white-coat hypertension
  • 24-h blood pressure

This article is cited by

Does the sympathetic nervous system increase or decrease blood pressure?

The increase in sympathetic activity is a mechanism for both initiating and sustaining the blood pressure elevation. Sympathetic nervous activation also confers specific cardiovascular risk.

Does the sympathetic nervous system cause high blood pressure?

Abstract. The sympathetic nervous system plays an important role in the regulation of arterial pressure, and increased sympathetic nervous system activity has been implicated as a primary precursor of hypertension in both humans and animal models of the disease.

How does the parasympathetic nervous system affect blood pressure?

The parasympathetic nervous system decreases respiration and heart rate and increases digestion. Stimulation of the parasympathetic nervous system results in: Construction of pupils. Decreased heart rate and blood pressure.